Adarx Pharmaceuticals: IPO Price Expected Between $15 And $17 Per Share
ABBV•IPO terms filed with SEC
- Adarx Pharmaceuticals said its IPO price is expected to be between $15 and $17 per share, according to an SEC filing.
- The company said it plans to offer 21,875,000 shares in the IPO.
- AbbVie Inc. said it will purchase 5,007,844 shares based on the IPO size, according to the filing.
